Speaker illustration

Doctor Martin Berger

RWTH University Hospital Aachen, Aachen (Germany)

Member of:

Heart Failure Association

Risk modifiers and mortality in patients with high platelet reactivity to Adenosine-diphosphate (ADP) in the LURIC study

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Biomarkers

Session: Atrial Fibrillation, Platelet Aggregation and Outcomes


Platelet complement C3 deposition predicts platelet hyperactivity in patients with type II diabetes

Event: ESC CONGRESS 2019

Topic: Platelets, Haemostasis, Coagulation

Session: The vascular inflammation coagulation interface


Dyslipidemia associated oxidised ldl induces platelet hyperactivity through a cd36-dependent activation of pde3a

Event: ESC Congress 2018

Topic: Platelets, Haemostasis, Coagulation

Session: Platelets, haemostasis and coagulation


Hyperlipidaemia associated oxidised phospholipids induce sustained platelet hyperactivity by CD36 and PLC gamma 2 dependent ROS production

Event: ESC CONGRESS 2017

Topic: Platelets

Session: State of the art in platelet biology


This platform is supported by

logo Novo Nordisk